NEW TAIPEI CITY, Taiwan, May 8, 2013 /PRNewswire/ --
Recall Managed By: Nephron Pharmaceuticals Corporation Health & Life Co., LTD 9F, No. 186, Jian Yi Road Zhonge District 23553 New Taipei City, Taiwan 886.2.82271300 www.healthandlife.com.tw
On May 8, 2013, Health & Life, Co., LTD, initiated a nationwide recall of 242,892 EZ Breathe™ Atomizers, Model #EZ-100, after becoming aware of an increase in the number of complaints. The Atomizers have been determined to have the possibility of a manufacturing defect which results in a quarter-inch diameter washer becoming dislodged from the EZ Breathe™ Atomizer, which potentially could result in a choking hazard. This product is manufactured by Health & Life Co., LTD. in Taiwan for Nephron Pharmaceuticals Corp., who is managing the recall activities. No injuries have been reported to date.
The EZ Breathe™Atomizer can be found in these three presentations:
1) Packaged in the Asthmanefrin® Starter Kit, NDC 0487-2784-10. Each Asthmanefrin® Starter Kit contains 10 vials of Asthmanefrin® medication that are manufactured by Nephron Pharmaceuticals Corp. and one EZ Breathe™ Atomizer.
Affected Asthmanefrin® Starter Kit Lot #'s: R2029A, R2029B, R2039A, R2042A, R2045A, and R2047A.
Recalled EZ Breathe™ Atomizers were manufactured from May 21, 2012 through October 29, 2012and distributed from August 3, 2012 through April 24, 2013.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Nephron Pharmaceuticals Corp. is notifying its distributors and customers by either direct mail, email or telephone and is arranging for the return of all recalled Atomizers. Nephron Pharmaceuticals Corp. distributed EZ Breathe™ Atomizers contained in Asthmanefrin® Starter Kits nationwide to drug wholesalers, pharmacies and individuals.
Consumers who have affected EZ Breathe™ Atomizers (as referenced above) should stop using, and contact the EZ Breathe Atomizer Recall Customer Care Center at 1-855-413-8920, between the hours of 8:00 am and 5:00 pm EDT, for return and replacement of their EZ Breathe™ Atomizer at no charge.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA:
Share this article